Dr. Daniela Panakova

For heart’s sake: DZHK grant goes to Daniela Panáková

Daniela Panáková is studying a signaling pathway that is of critical importance for the heart muscle and congenital heart defects. The German Centre for Cardiovascular Research (DZHK) has now awarded her a grant of €80,000 to support this research.
This signaling pathway is central to how organs acquire their shape. We are investigating what happens when this signaling pathway is disrupted.
Dr. Daniela Panakova
Daniela Panáková Head of the lab “Electrochemical Signaling in Development and Disease”

As the embryo grows in the womb, organs and muscles acquire form and function. The question of which mechanisms are involved in this process has long fascinated Dr. Daniela Panáková, who has headed the MDC’s Electrochemical Signaling in Development and Disease Lab since 2011. She is particularly interested in the PCP signaling pathway that cells of the heart and other organs use to order themselves during development. “This signaling pathway is central to how organs acquire their shape. We are investigating what happens when this signaling pathway is disrupted,” says Panáková. This can lead, among other things, to congenital heart defects, also known as congenital heart disease.

Back in 2018, international team of collaborators led by Daniela Panáková discovered that this signaling pathway plays a role in the early remodeling of the developing heart, the formation of the cardiac chambers, and the characteristic S-shaped form of the heart. In a new line of research, Panáková and her team demonstrate that the PCP signaling pathway is also involved in muscle differentiation: pathway deficiencies result in an abnormal development of the heart muscle. “This work was also supported by the DZHK. The new grant ties in with this and allows us to elucidate the underlying mechanisms in greater detail,” the researcher reports.

A domino effect that impacts the heart

The disruption of this signaling pathway has such a broad impact on the development and function of the whole heart because it affects the shape of the cell nucleus and thereby cellular gene expression. “The PCP signaling pathway influences the morphology of the cell nucleus, which presumably causes the chromatin to adopt a different structure,” Panáková explains. “This in turn affects gene expression, which is responsible for normal muscle function, and results in changes in cardiac muscle cell differentiation and consequently the functionality of the organ.”

The nuclei of developing heart muscle cells acquire their specific shape during embryonic heart remodelling. Vangl2 deficient nuclei are more deformed affecting mechanosensing at the nuclear envelope.

The link between the PCP signaling pathway and the cell nucleus is formed by the protein Vangl2, which is located on the cell surface. Daniela Panáková’s team now wants to find out how the communication between Vangl2 and the cell nucleus works, what other components are involved and how the information is passed on. The biologist also intends to analyze how the cell nucleus morphology actually changes. “We have a good understanding of the overall process, but still know very little about the details,” she says. But the details are the key to better understanding how congenital heart defects occur.

The funding line of the German Centre for Cardiovascular Research supporting Daniela Panáková’s work is geared toward helping outstanding female scientists with children continue their research on their path to professorship. “I think programs like these that promote women researchers are important,” says Panáková. “There are still too few of them in Germany.” The DZHK funding line was launched in 2019 and helps finance non-scientific staffing positions and materials in the funded project.

Text: Wiebke Peters


Further information